CS Medica is a Danish company active in medical technology. The company specializes in the development of new medical treatments. The portfolio includes medical cannabis (CBD) products, with the greatest focus on dietary supplements and various treatment care. The products are used, for example, by patients suffering from psoriasis, osteoarthritis, and hair loss. The largest operations are found in the Nordic market, where the products are resold under their own brand.

Quotes for CS MEDICA A/S

Right Now

+/-
0.2
%
2,61%
Latest
7.85
High
8
Low
7.05
Volume
39 153
Turnover (DKK)
297 880
Value (MDKK)
85,6

Board

CEO

  • Lone Henriksen

Chairperson of the Board

  • Jørgen Flemming Ladefoged

Board

  • Anders Permin
  • Bo Unéus
  • Gitte Lund Henriksen
  • Stein Løkstad

Largest Owners

Name Capital % Votes % Date
Gitte Henriksen 36,69 36,69 2021-09-14
Lone Henriksen 36,69 36,69 2021-09-14
Finn-Ove Henriksen and Nina Henriksen 3,34 3,34 2021-09-14
Ylber Rexhepi 2,32 2,32 2021-09-14
Tonoy Sayeed 1,46 1,46 2021-09-14
Kent Eklund 1,03 1,03 2021-09-14
Taulant Bara 1,03 1,03 2021-09-14
Thomas Gidlund 0,90 0,90 2021-09-14
Andreas Kjær 0,89 0,89 2021-09-14
Nils-Holger Olsson 0,77 0,77 2021-09-14
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-02-18 Delårsrapport 2022-Q1

  • 2022-05-20 Delårsrapport 2022-Q2

  • 2022-08-19 Delårsrapport 2022-Q3

  • 2022-11-18 Bokslutskommuniké 2022